Provided by Tiger Trade Technology Pte. Ltd.

Vericel

36.19
+0.81002.29%
Post-market: 36.02-0.1700-0.47%19:25 EST
Volume:499.00K
Turnover:17.98M
Market Cap:1.83B
PE:146.75
High:36.54
Open:35.69
Low:34.83
Close:35.38
52wk High:59.77
52wk Low:29.24
Shares:50.57M
Float Shares:49.90M
Volume Ratio:1.13
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2466
EPS(LYR):0.2000
ROE:4.52%
ROA:1.05%
PB:5.69
PE(LYR):180.95

Loading ...

Did Vericel's (VCEL) GARP Label and Debt-Free Balance Sheet Reframe Its Growth Narrative?

Simply Wall St.
·
Feb 04

Vericel: Strong MACI-Driven Performance, Robust Balance Sheet, and Multi-Pronged Growth Catalysts Support Buy Rating and $60 Target

TIPRANKS
·
Jan 20

A Look At Vericel (VCEL) Valuation After Strong Preliminary Growth And Profitability Guidance

Simply Wall St.
·
Jan 16

Vericel: Underappreciated High-Growth MACI Leader with Strengthening Profitability and a Long Runway Justifying Buy Rating

TIPRANKS
·
Jan 14

Vericel (VCEL) Is Down 7.0% After Issuing 2025 Revenue And Profitability Guidance - Has The Bull Case Changed?

Simply Wall St.
·
Jan 14

Vericel Corporation unveils presentation on advanced therapies for sports medicine and severe burn care

Reuters
·
Jan 14

Why Is Vericel Stock Gaining Tuesday?

Benzinga
·
Jan 14

Vericel Issues Strong Preliminary 2025 Financial Results

TIPRANKS
·
Jan 13

GUIDANCE: (VCEL) Vericel Expects 2025 Total Net Revenue About $276M, vs. FactSet Est of $274.1M

MT Newswires Live
·
Jan 13

Vericel reports Q4 total revenue of USD 276 million, up 23 percent

Reuters
·
Jan 13

Vericel Corp - Prelim FY2025 Gaap Net Income Profitability Expected

THOMSON REUTERS
·
Jan 13

Vericel Corp - Remain on Track to Begin Maci Commercial Manufacturing in New Facility in 2026

THOMSON REUTERS
·
Jan 13

Vericel Corp - Prelim FY2025 Total Net Revenue Expected to Be Approximately $276 Mln

THOMSON REUTERS
·
Jan 13

Vericel Outlook FY Revenue USD 239.5 Million

THOMSON REUTERS
·
Jan 13

Vericel Announces Preliminary 2025 Financial Results and Business Updates

GlobeNewswire
·
Jan 13

Vericel COO Michael Halpin Reports Disposal of Common Shares

Reuters
·
Jan 10

Vericel Corporation to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 06

Vericel Is Maintained at Buy by Truist Securities

Dow Jones
·
Dec 19, 2025

Truist Securities Adjusts Price Target on Vericel to $45 From $50, Maintains Buy Rating

MT Newswires Live
·
Dec 18, 2025

Vericel Director Paul K. Wotton Reports Sale of Common Shares

Reuters
·
Dec 05, 2025